Trgovina Beam Therapeutics Inc. - BEAM CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.12 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.030779% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.013666% | ||||||||
| Čas nočne pristojbine | 22:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | 48.72 |
| Odpri* | 48.16 |
| Enoletna sprememba* | -22.76% |
| Dnevni razpon* | 47.64 - 48.96 |
| Razpon 52 wk | 27.77-80.00 |
| Povprečni obseg (10 dni) | 799.61K |
| Povprečni obseg (3 meseci) | 17.05M |
| Tržna kapitalizacija | 3.41B |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 70.47M |
| Prihodki | 91.95M |
| EPS | -4.54 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | Feb 27, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 48.42 | 1.83 | 3.93% | 46.59 | 49.03 | 46.21 |
| Feb 2, 2023 | 48.72 | 0.75 | 1.56% | 47.97 | 50.66 | 46.47 |
| Feb 1, 2023 | 45.92 | 2.01 | 4.58% | 43.91 | 46.79 | 42.59 |
| Jan 31, 2023 | 43.36 | 1.27 | 3.02% | 42.09 | 44.14 | 42.09 |
| Jan 30, 2023 | 42.05 | -2.41 | -5.42% | 44.46 | 44.70 | 41.90 |
| Jan 27, 2023 | 45.22 | 2.01 | 4.65% | 43.21 | 45.91 | 43.21 |
| Jan 26, 2023 | 43.78 | -1.40 | -3.10% | 45.18 | 45.19 | 42.76 |
| Jan 25, 2023 | 44.36 | 1.27 | 2.95% | 43.09 | 44.45 | 41.61 |
| Jan 24, 2023 | 44.48 | 0.92 | 2.11% | 43.56 | 45.07 | 43.16 |
| Jan 23, 2023 | 44.31 | -0.01 | -0.02% | 44.32 | 45.04 | 42.56 |
| Jan 20, 2023 | 44.49 | 2.24 | 5.30% | 42.25 | 44.74 | 41.96 |
| Jan 19, 2023 | 42.38 | -1.06 | -2.44% | 43.44 | 43.48 | 41.62 |
| Jan 18, 2023 | 44.47 | -0.09 | -0.20% | 44.56 | 45.42 | 44.09 |
| Jan 17, 2023 | 44.38 | 1.52 | 3.55% | 42.86 | 44.90 | 42.64 |
| Jan 13, 2023 | 43.17 | 0.54 | 1.27% | 42.63 | 44.10 | 41.77 |
| Jan 12, 2023 | 43.30 | 1.91 | 4.61% | 41.39 | 43.40 | 39.96 |
| Jan 11, 2023 | 40.84 | 1.58 | 4.02% | 39.26 | 41.30 | 38.72 |
| Jan 10, 2023 | 39.38 | 0.89 | 2.31% | 38.49 | 39.56 | 38.46 |
| Jan 9, 2023 | 38.61 | -1.85 | -4.57% | 40.46 | 40.68 | 38.06 |
| Jan 6, 2023 | 40.30 | -0.73 | -1.78% | 41.03 | 41.19 | 39.17 |
Beam Therapeutics Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0 | 0 | 0.018 | 0.024 | 51.844 |
| Celotni odhodki iz poslovanja | 7.88 | 45.741 | 75.172 | 132.784 | 444.309 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 2.021 | 11.868 | 20.553 | 29.605 | 57.222 |
| Raziskave in razvoj | 5.859 | 33.873 | 54.619 | 103.179 | 387.087 |
| Prihodki iz poslovanja | -7.88 | -45.741 | -75.154 | -132.76 | -392.465 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -0.5 | -11.457 | -3.101 | -61.832 | -1.009 |
| Drugo, neto | 0.378 | -59.54 | -0.071 | 22.836 | |
| Čisti dobiček pred obdavčitvijo | -8.002 | -116.738 | -78.326 | -194.592 | -370.638 |
| Čisti dobiček po davkih | -8.002 | -116.738 | -78.326 | -194.592 | -370.638 |
| Manjšinski delež | 0 | 1.481 | 0 | ||
| Čisti dobiček pred dodatnimi postavkami | -8.002 | -115.257 | -78.326 | -194.592 | -370.638 |
| Čisti dobiček | -8.002 | -115.257 | -78.326 | -194.592 | -370.638 |
| Total Adjustments to Net Income | -1.685 | -2.068 | -12.714 | -1.277 | 0 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -9.687 | -117.325 | -91.04 | -195.869 | -370.638 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -9.687 | -117.325 | -91.04 | -195.869 | -370.638 |
| Popravljen čisti dobiček | -9.687 | -117.325 | -91.04 | -195.869 | -370.638 |
| Popravljene ponderirane povprečne delnice | 45.3248 | 45.3248 | 45.3248 | 46.7332 | 64.2277 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.21372 | -2.58854 | -2.00861 | -4.19122 | -5.77069 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.21372 | -2.58854 | -2.00861 | -4.19122 | -5.77069 |
| Prihodki | 0.018 | 0.024 | 51.844 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0.006 | 0.006 | 0.763 | 51.069 | 8.432 |
| Prihodki | 0.006 | 0.006 | 0.763 | 51.069 | 8.432 |
| Celotni odhodki iz poslovanja | 200.379 | 58.98 | 70.397 | 114.553 | 84.657 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 10.273 | 13.403 | 15.774 | 17.772 | 19.247 |
| Raziskave in razvoj | 190.106 | 45.577 | 54.623 | 96.781 | 65.41 |
| Prihodki iz poslovanja | -200.373 | -58.974 | -69.634 | -63.484 | -76.225 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -0.882 | -16.538 | 30.917 | -14.506 | 6.559 |
| Drugo, neto | -0.305 | -0.741 | 10.599 | 13.283 | 0.452 |
| Čisti dobiček pred obdavčitvijo | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Čisti dobiček po davkih | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Čisti dobiček pred dodatnimi postavkami | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Čisti dobiček | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Popravljen čisti dobiček | -201.56 | -76.253 | -28.118 | -64.707 | -69.214 |
| Popravljene ponderirane povprečne delnice | 60.2101 | 62.2102 | 66.3776 | 68.0301 | 68.7039 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -3.34761 | -1.22573 | -0.42361 | -0.95115 | -1.00743 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -3.34761 | -1.22573 | -0.42361 | -0.95115 | -1.00743 |
| Total Adjustments to Net Income | 0 | 0 | 0 |
- Letni
- Četrtletno
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 2.037 | 148.275 | 94.544 | 308.321 | 1273.01 |
| Denarna sredstva in kratkoročne naložbe | 1.901 | 146.443 | 91.848 | 299.671 | 965.647 |
| Denarna sredstva in ustrezniki | 1.901 | 146.443 | 37.221 | 162.171 | 559.994 |
| Prepaid Expenses | 0.136 | 1.832 | 2.696 | 8.65 | 7.36 |
| Total Assets | 2.402 | 167.012 | 156.099 | 451.677 | 1474.45 |
| Property/Plant/Equipment, Total - Net | 0.335 | 16.944 | 43.247 | 125.372 | 186.976 |
| Property/Plant/Equipment, Total - Gross | 0.346 | 17.605 | 47.411 | 134.271 | 203.057 |
| Accumulated Depreciation, Total | -0.011 | -0.661 | -4.164 | -8.899 | -16.081 |
| Other Long Term Assets, Total | 0.03 | 1.793 | 18.308 | 17.984 | 14.47 |
| Total Current Liabilities | 6.565 | 25.587 | 29.138 | 102.337 | 213.435 |
| Accounts Payable | 0.726 | 7.351 | 7.846 | 6.314 | 7.474 |
| Accrued Expenses | 0.129 | 1.734 | 12.189 | 22.705 | 75.204 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 13.75 | 1.303 | 2.118 | 2.287 |
| Other Current Liabilities, Total | 5.71 | 2.752 | 7.8 | 71.2 | 128.47 |
| Total Liabilities | 6.585 | 32.984 | 55.154 | 206.116 | 647.715 |
| Total Long Term Debt | 0 | 0 | 4.411 | 5.294 | 3.007 |
| Other Liabilities, Total | 0.02 | 7.397 | 21.605 | 98.485 | 431.273 |
| Total Equity | -4.183 | 134.028 | 100.945 | 245.561 | 826.738 |
| Redeemable Preferred Stock | 5.256 | 251.434 | 302.049 | 0 | 0 |
| Common Stock | 0.022 | 0.25 | 0.073 | 0.573 | 0.684 |
| Additional Paid-In Capital | 0 | 7.062 | 1.851 | 642.633 | 1594.38 |
| Retained Earnings (Accumulated Deficit) | -9.461 | -124.718 | -203.044 | -397.636 | -768.274 |
| Total Liabilities & Shareholders’ Equity | 2.402 | 167.012 | 156.099 | 451.677 | 1474.45 |
| Total Common Shares Outstanding | 45.3248 | 45.3248 | 45.3248 | 57.2542 | 68.3894 |
| Kratkoročne naložbe | 54.627 | 137.5 | 405.653 | ||
| Capital Lease Obligations | 4.411 | 5.294 | 3.007 | ||
| Other Equity, Total | 0.016 | -0.009 | -0.05 | ||
| Celotne terjatve, neto | 300 | ||||
| Accounts Receivable - Trade, Net | 300 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 514.58 | 677.993 | 941.424 | 1273.01 | 1239.48 |
| Denarna sredstva in kratkoročne naložbe | 503.479 | 615.279 | 933.405 | 965.647 | 1222.6 |
| Denarna sredstva in ustrezniki | 97.241 | 212.015 | 612.023 | 559.994 | 296.821 |
| Kratkoročne naložbe | 406.238 | 403.264 | 321.382 | 405.653 | 925.779 |
| Prepaid Expenses | 11.101 | 12.714 | 8.019 | 7.36 | 16.884 |
| Total Assets | 693.241 | 893.078 | 1156.56 | 1474.45 | 1453.4 |
| Property/Plant/Equipment, Total - Net | 158.788 | 169.658 | 174.702 | 186.976 | 199.831 |
| Property/Plant/Equipment, Total - Gross | 169.041 | 181.506 | 188.224 | 203.057 | 219.165 |
| Accumulated Depreciation, Total | -10.253 | -11.848 | -13.522 | -16.081 | -19.334 |
| Other Long Term Assets, Total | 19.873 | 15.997 | 15.891 | 14.47 | 14.087 |
| Total Current Liabilities | 102.086 | 128.715 | 101.391 | 213.435 | 218.798 |
| Accounts Payable | 7.983 | 8.03 | 7.282 | 7.474 | 6.266 |
| Accrued Expenses | 18.861 | 23.072 | 29.449 | 75.204 | 66.546 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2.142 | 2.189 | 2.238 | 2.287 | 2.337 |
| Other Current Liabilities, Total | 73.1 | 95.424 | 62.422 | 128.47 | 143.649 |
| Total Liabilities | 270.812 | 344.527 | 302.741 | 647.715 | 624.334 |
| Total Long Term Debt | 4.741 | 4.176 | 3.598 | 3.007 | 2.404 |
| Capital Lease Obligations | 4.741 | 4.176 | 3.598 | 3.007 | 2.404 |
| Other Liabilities, Total | 163.985 | 211.636 | 197.752 | 431.273 | 403.132 |
| Total Equity | 422.429 | 548.551 | 853.814 | 826.738 | 829.068 |
| Common Stock | 0.617 | 0.645 | 0.677 | 0.684 | 0.698 |
| Additional Paid-In Capital | 1021.03 | 1223.32 | 1556.69 | 1594.38 | 1668.57 |
| Retained Earnings (Accumulated Deficit) | -599.196 | -675.449 | -703.567 | -768.274 | -837.488 |
| Other Equity, Total | -0.024 | 0.031 | 0.019 | -0.05 | -2.709 |
| Total Liabilities & Shareholders’ Equity | 693.241 | 893.078 | 1156.56 | 1474.45 | 1453.4 |
| Total Common Shares Outstanding | 61.7351 | 64.4527 | 67.7345 | 68.3894 | 69.753 |
| Celotne terjatve, neto | 50 | 300 | 0 | ||
| Accounts Receivable - Trade, Net | 50 | 300 | 0 | ||
| Long Term Investments | 29.43 | 24.538 | |||
| Redeemable Preferred Stock | 0 | 0 |
- Letni
- Četrtletno
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -8.002 | -116.738 | -78.326 | -194.592 | -370.638 |
| Denarna sredstva iz poslovanja | -2.707 | -20.298 | -72.003 | -95.741 | -66.268 |
| Denarna sredstva iz poslovanja | 0.011 | 0.65 | 3.503 | 4.735 | 7.451 |
| Nedenarne postavke | 4.544 | 85.715 | 13.525 | 88.769 | 185.665 |
| Spremembe v obratnem kapitalu | 0.74 | 10.075 | -10.705 | 5.347 | 111.254 |
| Denarna sredstva pri naložbenju | -0.346 | -13.424 | -66.659 | -100.123 | -294.144 |
| Kapitalski izdatki | -0.346 | -13.124 | -12.518 | -16.357 | -46.811 |
| Celotne druge postavke denarnih tokov pri naložbenju | 0 | -0.3 | -54.141 | -83.766 | -247.333 |
| Denarna sredstva pri financiranju | 4.984 | 179.727 | 41.279 | 322.322 | 756.141 |
| Izdaja (odplačilo) delnic, neto | 4.984 | 179.727 | 38.086 | 322.683 | 767.075 |
| Neto sprememba denarnih sredstev | 1.931 | 146.005 | -97.383 | 126.458 | 395.729 |
| Postavke denarnega toka pri financiranju | -2.521 | -2.059 | -8.816 | ||
| Izdaja (odplačilo) dolga, neto | 5.714 | 1.698 | -2.118 | ||
| Denarna sredstva Plačane obresti | 0.561 | 0.567 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -201.56 | -277.813 | -305.931 | -370.638 | -69.214 |
| Cash From Operating Activities | -38.578 | -71.105 | -68.098 | -66.268 | 218.49 |
| Cash From Operating Activities | 1.398 | 3.067 | 4.817 | 7.451 | 3.312 |
| Non-Cash Items | 163.204 | 193.141 | 166.724 | 185.665 | 13.278 |
| Cash Interest Paid | 0.159 | 0.307 | 0.443 | 0.567 | 0.113 |
| Changes in Working Capital | -1.62 | 10.5 | 66.292 | 111.254 | 271.114 |
| Cash From Investing Activities | -279.626 | -292.763 | -216.648 | -294.144 | -537.339 |
| Capital Expenditures | -11.478 | -27.662 | -33.442 | -46.811 | -7.259 |
| Other Investing Cash Flow Items, Total | -268.148 | -265.101 | -183.206 | -247.333 | -530.08 |
| Cash From Financing Activities | 253.274 | 413.712 | 734.598 | 756.141 | 55.676 |
| Financing Cash Flow Items | -7.955 | -8.479 | -8.688 | -8.816 | -0.006 |
| Issuance (Retirement) of Stock, Net | 261.758 | 423.237 | 744.862 | 767.075 | 56.235 |
| Issuance (Retirement) of Debt, Net | -0.529 | -1.046 | -1.576 | -2.118 | -0.553 |
| Net Change in Cash | -64.93 | 49.844 | 449.852 | 395.729 | -263.173 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| ARK Investment Management LLC | Investment Advisor | 11.655 | 8213131 | -277805 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7472 | 6164096 | 927970 | 2022-09-30 | LOW |
| ARCH Venture Partners | Venture Capital | 8.2916 | 5843039 | -2030887 | 2021-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.399 | 4509330 | 200890 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 6.3775 | 4494135 | -215964 | 2022-09-30 | LOW |
| Farallon Capital Management, L.L.C. | Hedge Fund | 5.153 | 3631271 | 79500 | 2022-09-30 | MED |
| Temasek Holdings Pte. Ltd. | Sovereign Wealth Fund | 4.0674 | 2866268 | -1092944 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.6362 | 2562409 | -773918 | 2022-09-30 | LOW |
| MWG Management, Ltd. | Investment Advisor | 3.3305 | 2346934 | 0 | 2022-09-30 | MED |
| Redmile Group, LLC | Investment Advisor/Hedge Fund | 2.516 | 1772987 | -76900 | 2022-09-30 | LOW |
| Evans (John M.) | Individual Investor | 1.5798 | 1113238 | -30000 | 2022-10-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5673 | 1104475 | 137252 | 2022-09-30 | LOW |
| Deep Track Capital LP | Hedge Fund | 1.4191 | 1000000 | -250000 | 2022-09-30 | MED |
| SC China Holding Ltd | Investment Advisor | 1.1297 | 796089 | 0 | 2022-09-30 | LOW |
| Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.0149 | 715198 | 36929 | 2022-09-30 | LOW |
| Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 0.956 | 673690 | 162759 | 2022-12-31 | LOW |
| Bellevue Asset Management AG | Investment Advisor | 0.8113 | 571721 | -900 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7371 | 519418 | 29099 | 2022-09-30 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 0.7167 | 505039 | 6345 | 2022-09-30 | LOW |
| Baillie Gifford & Co. | Investment Advisor | 0.6454 | 454828 | 69610 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group +485000+
Borzni posredniki
65000+
Aktivne stranke mesečno
$48000000+
Mesečni obseg naložb
$28000000+
Preizkusi zdaj Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trgovalna provizija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Vzvod
20:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Beam Therapeutics Inc. Company profile
O družbi Beam Therapeutics Inc.
Beam Therapeutics Inc. je biotehnološko podjetje. Podjetje se osredotoča na razvoj preciznih genetskih zdravil, ki temeljijo na tehnologiji osnovnega urejanja, da bi bolnikom z boleznimi zagotovilo doživljenjsko zdravljenje. Njegova tehnologija urejanja baz omogoča nov razred natančnih genetskih zdravil, ki so usmerjena na eno samo bazo v genomu, ne da bi prišlo do dvoverižne prekinitve deoksiribonukleinske kisline (DNK). Družba s svojo tehnologijo urejanja baz za terapevtsko uporabo zasleduje nabor klinično potrjenih načinov in načinov dostave glede na vrsto tkiva, ki vključujejo elektroporacijo za dostavo v krvne in imunske celice ex vivo; lipidne nanodelce (LNP) za nevirusno dostavo in vivo v jetra in potencialno druge organe v prihodnosti ter adeno-asociirane virusne vektorje (AAV) za virusno dostavo in vivo v oko in potencialno druge organe. Družba ima štiri kandidate za razvoj, med katerimi so BEAM-101, BEAM-102, BEAM-201 in BEAM-301.
| Industry: | Biotechnology & Medical Research (NEC) |
26 Landsdowne St
CAMBRIDGE
MASSACHUSETTS 02139-4216
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 485.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com